biosimilars poised to impact specialty pharmacy
Published 9 years ago • 93 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
0:58
biosimilars in specialty pharmacy
-
1:00
the long-term impact of biosimilars on specialty pharmacy
-
1:33
the long-term impact of biosimilars
-
11:15
pricing of biosimilars with biologics and other biosimilars
-
3:03
challenges for payers with costs of biosimilars
-
16:50
sequencing osteoporosis drugs
-
2:52
how biologic medicines are made | how it's made
-
1:03:43
mabs biosimilars from lab to clinical
-
0:52
how specialty pharmacists can prepare patients to switch to biosimilars
-
1:27
what is the future of biosimilars?
-
4:06
overview and common misunderstandings of biosimilars
-
5:44
role of biosimilars in the specialty marketplace
-
0:20
what economic impact will biosimilars have in health care?
-
3:03
biosimilar medications — what patients need to know
-
1:27
how do biosimilars differ from generics?
-
1:00
biosimilars continue trending upward
-
0:54
how could biosimilars change the specialty drug landscape?
-
1:14
what has been the manufacturer response to biosimilars?
-
0:31
will biosimilars impact the cost of specialty drugs?
-
1:32
can biosimilars reduce specialty spending?
-
1:12
how will biosimilars impact the us?
-
6:16
cate lockhart of biologics & biosimilars collective intelligence consortium presents at pbmi